Permanent Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Permanent Capital Management's ABBV Position: Q3 2026 in Review
Permanent Capital Management reduced its AbbVie (ABBV) stake by 76% in Q3 2026, selling an estimated $708K and leaving 859 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #20.
Permanent Capital Management first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $911K in Q2 2026. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Permanent Capital Management held 859 shares of AbbVie worth $225K as of Q3 2026.
- Permanent Capital Management sold 2,763 AbbVie shares in Q3 2026, an estimated $708K.
- AbbVie made up 0.04% of Permanent Capital Management's portfolio in Q3 2026, its #20 holding.
- Permanent Capital Management first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
- Permanent Capital Management's AbbVie position peaked at $911K in Q2 2026.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Permanent Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.